Recruiting EARLY_PHASE1 Polycystic Ovary Syndrome

New treatment option for Polycystic Ovary Syndrome

Official title The Effect of Therapy Combination in PCOS With Dlbs 3233

ClinicalTrials.gov ID: NCT07403201

What this study is testing

What is dlbs 3233 , clomifen citrat?

dlbs 3233 , clomifen citrat is an investigational medicine, being studied as a potential treatment for polycystic ovary syndrome.

Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.

What it's testing
The effect of combination therapy dlbs 3233 and clomifen citrate vs clomifen citrate on homa ir, maturation follicle, and menstrual cycle in PCOS cases at Muhammadiyah Asri Medical Center Hospital
  • Phase 1: an early, usually small safety study

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages up to 45, women only

You may be able to join if

  • married agree to join this research

You likely can't join if

  • dis agree to join research

The study team makes the final eligibility decision.

Where it's taking place

  • Yogyakarta, DIY, Indonesia

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling female, up to 45 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Yogyakarta, DIY, Indonesia. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.